DEA Inaction on Fentanyl
Records show the DEA watched as staggering amounts of fentanyl hit the streets without taking action
A recent whistleblower disclosure has shed light on the inaction of the DEA in regards to the staggering amounts of fentanyl hitting the streets, with records showing that agents permitted the delivery of at least 1.8 million fentanyl pills, as reported by PBS News. This lack of action has raised questions about the agency's handling of the crisis, particularly in light of the ongoing Covid Transparency Fight and the release of documents related to Fauci's testimony, which has sparked debate about the handling of whistleblower complaints, as seen in the recent Fauci Docs Reveal Biden Admin Intervention article.
The DEA's inaction on fentanyl is particularly troubling given the severity of the crisis, with millions of pills flooding the streets and causing widespread harm. The agency's failure to take action has been likened to the mishandling of confidential client information by KPMG Australia, which led to the resignation of chair Martin Sheppard, as reported by abc.net.au. The similarities between the two cases highlight the need for greater transparency and accountability in government agencies and private companies alike.
As the fentanyl crisis continues to worsen, lawmakers are calling for greater action to be taken to address the issue. The lack of action by the DEA has been criticized, with some arguing that it is a symptom of a larger problem of government secrecy and inaction, as seen in the Congress Hides AI Probe scandal. The need for greater transparency and accountability is clear, and it remains to be seen whether the government will take the necessary steps to address the crisis. In the meantime, the public can stay informed about the latest developments through reputable news sources, such as cnn.com, which provides up-to-date coverage of the ongoing debate over Covid-19 documents and whistleblower complaints.
As I reflect on the DEA's inaction on fentanyl, I firmly believe that their lack of urgency is a dereliction of duty. The devastating impact of this synthetic opioid is undeniable, yet the agency's slow response is allowing the crisis to worsen. If nothing changes, the cartels and illicit manufacturers will continue to win, profiting from the suffering and death of thousands of Americans. Their inaction is a clear victory for those who seek to exploit and harm our communities, and it's imperative that we demand more from our regulatory agencies to combat this epidemic effectively.
Cross-reference independently — do not take our word for it.
Disclosure: NewsAnarchist uses AI-assisted reporting with web search. Always verify primary sources linked above.